AI Terminal
LIFE SCIENCE REIT PLC
Director's Dealing • Dec 6, 2022
5353_dirs_2022-12-06_2f956f72-f808-4474-9614-495932737e9f.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 7955I
Life Science REIT PLC
06 December 2022
Life Science REIT Plc
(the "Company")
LEI: 213800RG7JNX7K8F7525
Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them.
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Mr Richard Howell
2.
Reason for the notification
a)
Position / status
Non-Executive Director
b)
Initial notification / amendment
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Life Science REIT Plc
b)
LEI
213800RG7JNX7K8F7525
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Identification Code
Ordinary Shares of 1 pence each
ISIN: GB00BP5X4Q29
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.74195 | 30,000 |
d)
Aggregated information
-Aggregated volume
-Price
30,000
£22,258.50
e)
Date of the transaction
6 December 2022
f)
Place of the transaction
London Stock Exchange (XLON)
For further information, please contact:
Michael Conway
Link Company Matters Limited
Company Secretary
+44 (0) 7936 332298
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFSDFLMEESEEE